Clinical characteristics and outcomes of patients with Guillain–Barré and acquired CNS demyelinating overlap syndrome: a cohort study based on a literature review

2014 ◽  
Vol 36 (12) ◽  
pp. 1106-1113 ◽  
Author(s):  
Zhifeng Mao ◽  
Xueqiang Hu
2020 ◽  
Vol 158 (6) ◽  
pp. S-1161
Author(s):  
Amrit K. Kamboj ◽  
Amandeep Gujral ◽  
Elida Voth ◽  
Daniel Penrice ◽  
Jessica McGoldrick ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Rujipas Sirijatuphat ◽  
Yupin Suputtamongkol ◽  
Nasikarn Angkasekwinai ◽  
Navin Horthongkham ◽  
Methee Chayakulkeeree ◽  
...  

Abstract Background The epidemiology and outcomes of COVID-19 patients in Thailand are scarce. Methods This retrospective cohort study included adult hospitalized patients who were diagnosed with COVID-19 at Siriraj Hospital during February 2020 to April 2020. Results The prevalence of COVID-19 was 7.5% (107 COVID-19 patients) among 1409 patients who underwent RT-PCR for SARS-CoV-2 detection at our hospital during the outbreak period. Patients with COVID-19 presented with symptoms in 94.4%. Among the 104 patients who were treated with antiviral medications, 78 (75%) received 2-drug regimen (lopinavir/ritonavir or darunavir/ritonavir plus chloroquine or hydroxychloroquine), and 26 (25%) received a 3-drug regimen with favipiravir added to the 2-drug regimen. Disease progression was observed in 18 patients (16.8%). All patients with COVID-19 were discharged alive. Conclusions The prevalence of COVID-19 was 7.5% among patients who underwent RT-PCR testing, and 10% among those having risk factors for COVID-19 acquisition. Combination antiviral therapies for COVID-19 patients were well-tolerated and produced a favorable outcome.


2009 ◽  
Vol 23 (4) ◽  
pp. 484-489 ◽  
Author(s):  
Jose L. Del Pozo ◽  
Diederik van de Beek ◽  
Richard C. Daly ◽  
Jose S. Pulido ◽  
Christopher G.A. McGregor ◽  
...  

Medicine ◽  
2017 ◽  
Vol 96 (1) ◽  
pp. e5848 ◽  
Author(s):  
Bing Zhang ◽  
Xiujuan Wu ◽  
Donghui Shen ◽  
Ting Li ◽  
Chunrong Li ◽  
...  

2014 ◽  
Vol 50 (3) ◽  
pp. 350-360 ◽  
Author(s):  
Ryosuke Tateishi ◽  
Takeshi Okanoue ◽  
Naoto Fujiwara ◽  
Kiwamu Okita ◽  
Kendo Kiyosawa ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document